Estados financieros detallados de Trevi Therapeutics, Inc. (TRVI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $15.89, TRVI presenta beneficios negativos (P/E no significativo) y un ROE del -23.59%. La capitalización bursátil es de $2.3B.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $4000 | 0 | $23000 | $39000 | $47000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$4000 | 0 | -$23000 | -$39000 | -$47000 | 0 | 0 | 0 | 0 | 0 |
| I+D | $6.9M | $6.1M | $14.1M | $19.3M | $22.3M | $23.0M | $19.8M | $23.7M | $39.4M | $33.5M |
| Generales y Administrativos | $1.7M | $2.1M | $4.3M | $7.3M | $10.2M | $9.5M | $10.1M | $10.2M | $12.1M | $15.8M |
| Gastos Operativos | $8.6M | $8.2M | $18.4M | $26.6M | $32.5M | $32.5M | $29.9M | $33.9M | $51.5M | $49.3M |
| Beneficio Operativo | -$8.6M | -$8.2M | -$18.4M | -$26.6M | -$32.5M | -$32.5M | -$29.9M | -$33.9M | -$51.5M | -$49.3M |
| EBITDA | -$8.6M | -$8.2M | -$18.4M | -$26.6M | -$32.3M | -$32.7M | -$28.0M | -$28.6M | -$47.8M | -$42.7M |
| Gastos por Intereses | 0 | $3.3M | $174000 | 0 | $456000 | $1.2M | $780000 | $391000 | $4000 | 0 |
| Beneficio Antes de Impuestos | -$11.1M | -$12.9M | -$20.7M | -$26.1M | -$32.8M | -$34.0M | -$29.2M | -$29.1M | -$47.9M | -$42.8M |
| Impuestos | -$8000 | -$26000 | -$124000 | -$18000 | -$18000 | -$21000 | -$36000 | -$32000 | -$30000 | -$64000 |
| Beneficio Neto | -$11.1M | -$12.9M | -$20.5M | -$26.1M | -$32.8M | -$33.9M | -$29.2M | -$29.1M | -$47.9M | -$42.8M |
| BPA | $-0.69 | $-1.43 | $-2.29 | $-1.46 | $-1.81 | $-1.49 | $-0.45 | $-0.29 | $-0.47 | $-0.29 |
| BPA Diluido | $-0.69 | $-1.43 | $-2.29 | $-1.46 | $-1.81 | $-1.49 | $-0.45 | $-0.29 | $-0.47 | $-0.29 |
| Acciones en Circulación (Diluidas) | $16.1M | $9.0M | $9.0M | $17.8M | $18.1M | $22.8M | $64.5M | $99.0M | $101.0M | $145.1M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8.3M | $22.0M | $17.2M | $57.3M | $45.0M | $36.8M | $12.6M | $32.4M | $34.1M | $18.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $107.9M | $50.6M | $73.5M | $169.3M |
| Cuentas por Cobrar | $19000 | 0 | $184000 | $558000 | 0 | $241000 | 0 | 0 | $532000 | $986000 |
| Inventario | 0 | $63000 | $1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $8.4M | $22.2M | $18.8M | $59.6M | $46.3M | $38.0M | $122.6M | $87.5M | $109.4M | $191.7M |
| Inmovilizado Material | $5000 | $14000 | $149000 | $430000 | $330000 | $184000 | $194000 | $1.6M | $1.2M | $855000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $8.4M | $22.2M | $20.5M | $60.0M | $47.1M | $38.5M | $123.0M | $89.4M | $110.9M | $193.4M |
| Cuentas por Pagar | $445000 | $537000 | $603000 | $1.6M | $2.0M | $2.8M | $2.9M | $1.8M | $3.4M | $3.9M |
| Deuda a Corto | $17.0M | $5.3M | 0 | 0 | 0 | $5.8M | $7.0M | 0 | 0 | 0 |
| Pasivos Corrientes | $20.4M | $7.1M | $2.7M | $5.2M | $5.6M | $12.7M | $13.4M | $5.8M | $10.5M | $9.7M |
| Deuda a Largo | $5.1M | 0 | $1.1M | 0 | $14.0M | $8.7M | $2.2M | 0 | 0 | 0 |
| Pasivos Totales | $25.8M | $7.5M | $3.2M | $5.5M | $19.8M | $21.4M | $15.6M | $6.9M | $11.3M | $10.2M |
| Reservas | -$72.2M | -$84.4M | -$109.5M | -$114.2M | -$147.0M | -$180.9M | -$210.1M | -$239.1M | -$287.0M | -$329.8M |
| Patrimonio Neto | -$17.4M | $14.8M | $17.3M | $54.5M | $27.3M | $17.1M | $107.5M | $82.5M | $99.6M | $183.2M |
| Deuda Total | $22.1M | $5.3M | $1.1M | $356000 | $14.2M | $14.6M | $9.2M | $1.3M | $1.0M | $753000 |
| Deuda Neta | $13.8M | -$16.7M | -$16.1M | -$57.0M | -$30.8M | -$22.2M | -$111.3M | -$81.6M | -$106.6M | -$187.5M |
| Capital Circulante | -$12.0M | $15.0M | $16.1M | $54.4M | $40.7M | $25.2M | $109.2M | $81.7M | $98.9M | $181.9M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -16.0% | -59.8% | -26.8% | -25.8% | -3.6% | +14.1% | +0.3% | -64.8% | +10.8% | |
| Crecimiento BPA (anual) | -107.2% | -60.1% | +36.2% | -24.0% | +17.7% | +69.8% | +35.6% | -62.1% | +38.3% | |
| Cambio en Acciones (anual) | -44.4% | +0.0% | +98.9% | +1.3% | +26.5% | +182.6% | +53.4% | +2.0% | +43.6% | |
| Tasa Impositiva Efectiva | 0.1% | 0.2% | 0.6% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -23.59% |
| Rentabilidad sobre capital invertido | -18.46% |
| Rentabilidad sobre activos | -15.46% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 37.28 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 104.82 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -11.43 | -5.52 | -3.45 | -2.57 | -1.34 | -0.52 | -4.29 | -4.62 | -8.77 | -43.17 |
| P/VC | -7.31 | 4.79 | 4.09 | 1.23 | 1.60 | 1.05 | 1.16 | 1.61 | 4.18 | 9.91 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ARDX · NVAX · ORIC · PGEN · TERN · TRML · UPB
Explorar sector: Healthcare · Biotechnology
Más secciones de TRVI: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones